Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
A recombinant vector comprises simian adenovirus 43, 45, 46, 47, 48, 49 or 50 sequences and a heterologous gene under the control of regulatory sequences. A cell line which expresses simian adenovirus 43, 45, 46, 47, 48, 49 or 50 gene(s) is also disclosed. Methods of using the vectors and cell lines are provided.
1. An adenovirus having a capsid comprising a hexon protein, a penton protein, and fiber protein, said hexon protein being a hexon protein of SAdV-46 comprising amino acids 1 to 959 of SEQ ID NO: 79;
said capsid encapsidating a heterologous molecule comprising a gene operably linked to expression control sequences which direct transcription, translation, and/or expression thereof in a host cell.
2. The adenovirus according to claim 1 , further comprising a 5′ and a 3′ adenovirus cis-elements necessary for replication and encapsidation.
3. The adenovirus according to claim 1 , wherein said adenovirus lacks all or a part of the E1 gene.
4. The adenovirus according to claim 3 , wherein said adenovirus is replication—defective.
5. The adenovirus according to claim 1 , wherein said capsid is a hybrid capsid comprising at least one capsid protein from an adenovirus other than SAdV-46.
6. The recombinant adenovirus according to claim 5 , wherein the capsid protein from an adenovirus other than SAdV-46 in the hybrid capsid is from SAdV-43, SAdV-45, SAdV-47, SAdV-48, SAdV-49, or SAdV-50.
7. A composition comprising the recombinant adenovirus according to claim 1 in a pharmaceutically acceptable carrier.
8. A recombinant adenovirus having a capsid comprising a fiber protein, a penton protein and a hexon protein, said hexon comprising (a) the full-length of amino acids 51 to 959 of SEQ ID NO: 79 from SAdV-46 or (b) the full-length of amino acids 1 to 909 of SEQ ID NO: 79 from SAdV-46 said adenovirus capsid encapsidating a heterologous molecule carrying comprising a gene operably linked to expression control sequences which direct transcription, translation, and/or expression thereof in a host cell.
9. The recombinant adenovirus according to claim 8 , wherein the capsid is a hybrid capsid which comprises a capsid protein from an adenovirus other than SAdV-46, said capsid protein being a fiber protein from SAdV-43, SAdV-45, SAdV-47, SAdV-48, SAdV-49, or SAdV-50.
10. The recombinant adenovirus according to claim 8 , wherein the capsid protein from an adenovirus other than SAdV-46, said capsid protein being a penton protein from SAdV-43, SAdV-45, SAdV-47, SAdV-48, SAdV-49, or SAdV-50.
11. The recombinant adenovirus according to claim 8 , wherein said adenovirus is a pseudotyped adenovirus comprising a 5′ and a 3′ adenovirus cis-element necessary for replication and encapsidation, wherein the cis-elements comprising an adenovirus 5′ inverted terminal repeat and an adenovirus 3′ inverted terminal repeat.
12. The recombinant adenovirus according to claim 8 , wherein the recombinant adenovirus comprises one or more adenovirus genes.
13. The recombinant adenovirus according to claim 8 , wherein the recombinant adenovirus is replication—defective.
14. The recombinant adenovirus according to claim 13 , wherein the recombinant adenovirus comprises a deletion in the adenovirus E1 region.